Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study

Yamada,Yoshiji; Matsui,Kota; Takeuchi,Ichiro; Fujimaki,Tetsuo

doi:10.3892/ijmm.2015.2152

Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study

Authors:
- Yoshiji Yamada
- Kota Matsui
- Ichiro Takeuchi
- Tetsuo Fujimaki
View Affiliations

Affiliations: Department of Human Functional Genomics, Life Science Research Center, Mie University, Tsu, Mie 514‑8507, Japan, Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency, Tokyo 102‑0076, Japan, Department of Cardiovascular Medicine, Inabe General Hospital, Inabe, Mie 511‑0428, Japan
Published online on: March 20, 2015 https://doi.org/10.3892/ijmm.2015.2152
Pages: 1290-1300
Copyright: © Yamada et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

We previously identified 9 genes and chromosomal region 3q28 as susceptibility loci for myocardial infarction, ischemic stroke, or chronic kidney disease (CKD) in Japanese individuals by genome‑wide or candidate gene association studies. In the present study, we examined the association of 13 polymorphisms at these 10 loci with the prevalence of hypertriglyceridemia, hyper‑low‑density lipoprotein (LDL) cholesterolemia, hypo‑high‑density lipoprotein (HDL) cholesterolemia, or CKD in community‑dwelling Japanese individuals. The study subjects comprised 6,027 individuals who were recruited to the Inabe Health and Longevity Study, a longitudinal genetic epidemiological study of atherosclerotic, cardiovascular and metabolic diseases. The subjects were recruited from individuals who visited the Health Care Center at Inabe General Hospital for an annual health checkup, and they were followed up each year (mean follow‑up period, 5 years). Longitudinal analysis with a generalized estimating equation and with adjustment for covariates revealed that rs6929846 of butyrophilin, subfamily 2, member A1 gene (BTN2A1) was significantly associated with the prevalence of hypertriglyceridemia (P=0.0001), hyper‑LDL cholesterolemia (P=0.0004), and CKD (P=0.0007); rs2569512 of interleukin enhancer binding factor 3 (ILF3) was associated with hyper‑LDL cholesterolemia (P=0.0029); and rs2074379 (P=0.0019) and rs2074388 (P=0.0029) of alpha-kinase 1 (ALPK1) were associated with CKD. Longitudinal analysis with a generalized linear mixed‑effect model and with adjustment for covariates among all individuals revealed that rs6929846 of BTN2A1 was significantly associated with the serum concentrations of triglycerides (P=0.0011), LDL cholesterol (P=3.3x10‑5), and creatinine (P=0.0006), as well as with the estimated glomerular filtration rate (eGFR) (P=0.0004); rs2569512 of ILF3 was shown to be associated with the serum concentration of LDL cholesterol (P=0.0221); and rs2074379 (P=0.0302) and rs2074388 (P=0.0336) of ALPK1 were shown to be associated with the serum concentration of creatinine. Similar analysis among individuals not taking any anti‑dyslipidemic medication revealed that rs6929846 of BTN2A1 was significantly associated with the serum concentrations of triglycerides (P=8.3x10‑5) and LDL cholesterol (P=0.0004), and that rs2569512 of ILF3 was associated with the serum concentration of LDL cholesterol (P=0.0010). BTN2A1 may thus be a susceptibility gene for hypertriglyceridemia, hyper‑LDL cholesterolemia and CKD in Japanese individuals.

View Figures

View References

1	Heller DA, de Faire U, Pedersen NL, Dahlén G and McClearn GE: Genetic and environmental influences on serum lipid levels in twins. N Engl J Med. 328:1150–1156. 1993. View Article : Google Scholar : PubMed/NCBI
2	Ordovas JM: Nutrigenetics, plasma lipids, and cardiovascular risk. J Am Diet Assoc. 106:1074–1081. 2006. View Article : Google Scholar : PubMed/NCBI
3	Go AS, Mozaffarian D, Roger VL, et al: American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics - 2014 update: A report from the American Heart Association. Circulation. 129. pp. e28–e292. 2014, View Article : Google Scholar
4	Takamatsu N, Abe H, Tominaga T, Nakahara K, Ito Y, Okumoto Y, Kim J, Kitakaze M and Doi T: Risk factors for chronic kidney disease in Japan: A community-based study. BMC Nephrol. 10:342009. View Article : Google Scholar : PubMed/NCBI
5	Willer CJ, Schmidt EM, Sengupta S, et al: Global Lipids Genetics Consortium: Discovery and refinement of loci associated with lipid levels. Nat Genet. 45:1274–1283. 2013. View Article : Google Scholar : PubMed/NCBI
6	Teslovich TM, Musunuru K, Smith AV, et al: Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 466:707–713. 2010. View Article : Google Scholar : PubMed/NCBI
7	Aulchenko YS, Ripatti S, Lindqvist I, et al: ENGAGE Consortium: Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet. 41:47–55. 2009. View Article : Google Scholar :
8	Kathiresan S, Willer CJ, Peloso GM, et al: Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 41:56–65. 2009. View Article : Google Scholar
9	Kathiresan S, Melander O, Guiducci C, et al: Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 40:189–197. 2008. View Article : Google Scholar : PubMed/NCBI
10	Yamada Y, Matsuo H, Warita S, et al: Prediction of genetic risk for dyslipidemia. Genomics. 90:551–558. 2007. View Article : Google Scholar : PubMed/NCBI
11	Yamada Y, Kato K, Hibino T, et al: Prediction of genetic risk for metabolic syndrome. Atherosclerosis. 191:298–304. 2007. View Article : Google Scholar
12	Yamada Y, Ichihara S, Kato K, et al: Genetic risk for metabolic syndrome: Examination of candidate gene polymorphisms related to lipid metabolism in Japanese people. J Med Genet. 45:22–28. 2008. View Article : Google Scholar
13	James MT, Hemmelgarn BR and Tonelli M: Early recognition and prevention of chronic kidney disease. Lancet. 375:1296–1309. 2010. View Article : Google Scholar : PubMed/NCBI
14	Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS and Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol. 15:1307–1315. 2004. View Article : Google Scholar : PubMed/NCBI
15	Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT, Chronic Kidney and Disease Prognosis: Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet. 375:2073–2081. 2010. View Article : Google Scholar : PubMed/NCBI
16	National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 39(Suppl 1): S1–S266. 2002.PubMed/NCBI
17	Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M and Koyama A: Risk factors for chronic kidney disease in a community-based population: A 10-year follow-up study. Kidney Int. 71:159–166. 2007. View Article : Google Scholar
18	Friedman DJ and Pollak MR: Genetics of kidney failure and the evolving story of APOL1. J Clin Invest. 121:3367–3374. 2011. View Article : Google Scholar : PubMed/NCBI
19	Köttgen A, Glazer NL, Dehghan A, et al: Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet. 41:712–717. 2009. View Article : Google Scholar : PubMed/NCBI
20	Chambers JC, Zhang W, Lord GM, et al: Genetic loci influencing kidney function and chronic kidney disease. Nat Genet. 42:373–375. 2010. View Article : Google Scholar : PubMed/NCBI
21	Köttgen A, Pattaro C, Böger CA, et al: New loci associated with kidney function and chronic kidney disease. Nat Genet. 42:376–384. 2010. View Article : Google Scholar : PubMed/NCBI
22	Böger CA, Gorski M, Li M, et al: CKDGen Consortium: Association of eGFR-related loci identified by GWAS with incident CKD and ESRD. PLoS Genet. 7:e10022922011. View Article : Google Scholar
23	Pattaro C, Köttgen A, Teumer A, et al: CARDIoGRAM Consortium; ICBP Consortium; CARe Consortium; Wellcome Trust Case Control Consortium 2 (WTCCC2): Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet. 8:e10025842012. View Article : Google Scholar
24	Kao WH, Klag MJ, Meoni LA, et al: Family Investigation of Nephropathy and Diabetes Research Group: MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet. 40:1185–1192. 2008. View Article : Google Scholar : PubMed/NCBI
25	Liu CT, Garnaas MK, Tin A, et al: CKDGen Consortium: Genetic association for renal traits among participants of African ancestry reveals new loci for renal function. PLoS Genet. 7:e10022642011. View Article : Google Scholar
26	Okada Y, Sim X, Go MJ, et al: KidneyGen Consortium; CKDGen Consortium; GUGC consortium: Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations. Nat Genet. 44:904–909. 2012. View Article : Google Scholar : PubMed/NCBI
27	Yamada Y, Nishida T, Ichihara S, et al: Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations. Atherosclerosis. 215:145–152. 2011. View Article : Google Scholar : PubMed/NCBI
28	Yamada Y, Fuku N, Tanaka M, et al: Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis. 207:144–149. 2009. View Article : Google Scholar : PubMed/NCBI
29	Yamada Y, Nishida T, Ichihara S, et al: Identification of chromosome 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals by a genome-wide association study. J Med Genet. 50:410–418. 2013. View Article : Google Scholar : PubMed/NCBI
30	Yamada Y, Matsuo H, Segawa T, et al: Assessment of genetic risk for myocardial infarction. Thromb Haemost. 96:220–227. 2006.PubMed/NCBI
31	Fujimaki T, Kato K, Yoshida T, et al: Association of genetic variants with myocardial infarction in Japanese individuals with chronic kidney disease. Thromb Haemost. 101:963–968. 2009.PubMed/NCBI
32	Oguri M, Kato K, Yokoi K, et al: Association of genetic variants with myocardial infarction in Japanese individuals with metabolic syndrome. Atherosclerosis. 206:486–493. 2009. View Article : Google Scholar : PubMed/NCBI
33	Yamada Y, Matsui K, Takeuchi I, Oguri M and Fujimaki T: Association of genetic variants with hypertension in a longitudinal population-based genetic epidemiological study. Int J Mol Med. 35:1189–1198. 2015.
34	Shimokata S, Oguri M, Fujimaki T, Horibe H, Kato K and Yamada Y: Association between polymorphisms of the α-kinase 1 gene and type 2 diabetes mellitus in community-dwelling individuals. Biomed Rep. 1:940–944. 2013.
35	Ueyama C, Horibe H, Fujimaki T, Oguri M, Kato K and Yamada Y: Association of genetic variants of CELSR1 and 3q28 with hypertension in community-dwelling individuals. Biomed Rep. 1:840–844. 2013.
36	Oguri M, Fujimaki T, Horibe H, Kato K, Ichihara S and Yamada Y: Association of a polymorphism of BTN2A1 with chronic kidney disease in community-dwelling individuals. Biomed Rep. 1:868–872. 2013.
37	Fujimaki T, Horibe H, Oguri M, Kato K and Yamada Y: Association of genetic variants of the α-kinase 1 gene with myocardial infarction in community-dwelling individuals. Biomed Rep. 2:127–131. 2014.PubMed/NCBI
38	Horibe H, Ueyama C, Fujimaki T, Oguri M, Kato K, Ichihara S and Yamada Y: Association of a polymorphism of BTN2A1 with dyslipidemia in community-dwelling individuals. Mol Med Rep. 9:808–812. 2014.PubMed/NCBI
39	Murakata Y, Fujimaki T and Yamada Y: Association of a butyrophilin, subfamily 2, member A1 gene polymorphism with hypertension. Biomed Rep. 2:818–822. 2014.PubMed/NCBI
40	Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H and Hishida A; Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 53:982–992. 2009. View Article : Google Scholar : PubMed/NCBI
41	Itoh Y, Mizuki N, Shimada T, Azuma F, Itakura M, Kashiwase K, Kikkawa E, Kulski JK, Satake M and Inoko H: High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics. 57:717–729. 2005. View Article : Google Scholar : PubMed/NCBI
42	Gibbons RD, Hedeker D and DuToit S: Advances in analysis of longitudinal data. Annu Rev Clin Psychol. 6:79–107. 2010. View Article : Google Scholar : PubMed/NCBI
43	Cheng J, Edwards LJ, Maldonado-Molina MM, Komro KA and Muller KE: Real longitudinal data analysis for real people: Building a good enough mixed model. Stat Med. 29:504–520. 2010.
44	Fujimaki T, Kato K, Oguri M, et al: Association of a polymorphism of BTN2A1 with dyslipidemia in East Asian populations. Exp Ther Med. 2:745–749. 2011.PubMed/NCBI
45	Yoshida T, Kato K, Horibe H, Oguri M, Fukuda M, Satoh K, Aoyagi Y, Shinkai S, Nozawa Y and Yamada Y: Association of a genetic variant of BTN2A1 with chronic kidney disease in Japanese individuals. Nephrology (Carlton). 16:642–648. 2011.
46	Arnett HA, Escobar SS and Viney JL: Regulation of costimulation in the era of butyrophilins. Cytokine. 46:370–375. 2009. View Article : Google Scholar : PubMed/NCBI
47	Oguri M, Kato K, Yoshida T, et al: Association of a genetic variant of BTN2A1 with metabolic syndrome in East Asian populations. J Med Genet. 48:787–792. 2011. View Article : Google Scholar : PubMed/NCBI
48	Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR and Grunfeld C: Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J Lipid Res. 45:1169–1196. 2004. View Article : Google Scholar : PubMed/NCBI
49	Esteve E, Ricart W and Fernández-Real JM: Dyslipidemia and inflammation: An evolutionary conserved mechanism. Clin Nutr. 24:16–31. 2005. View Article : Google Scholar : PubMed/NCBI
50	McGillicuddy FC, de la Llera Moya M, Hinkle CC, Joshi MR, Chiquoine EH, Billheimer JT, Rothblat GH and Reilly MP: Inflammation impairs reverse cholesterol transport in vivo. Circulation. 119:1135–1145. 2009. View Article : Google Scholar : PubMed/NCBI
51	Reiss AB: Effects of inflammation on cholesterol metabolism: Impact on systemic lupus erythematosus. Curr Rheumatol Rep. 11:255–260. 2009. View Article : Google Scholar : PubMed/NCBI
52	Kawakami T, Mimura I, Shoji K, Tanaka T and Nangaku M: Hypoxia and fibrosis in chronic kidney disease: Crossing at pericytes. Kidney Int Suppl. 2011.4:107–112. 2014. View Article : Google Scholar
53	Schnaper HW and Kopp JB: Why kidneys fail: Report from an American Society of Nephrology Advances in Research Conference. J Am Soc Nephrol. 17:1777–1781. 2006. View Article : Google Scholar : PubMed/NCBI
54	Ricardo SD, van Goor H and Eddy AA: Macrophage diversity in renal injury and repair. J Clin Invest. 118:3522–3530. 2008. View Article : Google Scholar : PubMed/NCBI
55	Brosius FC III: New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy. Rev Endocr Metab Disord. 9:245–254. 2008. View Article : Google Scholar : PubMed/NCBI
56	Shim J, Lim H, R Yates J and Karin M: Nuclear export of NF90 is required for interleukin-2 mRNA stabilization. Mol Cell. 10:1331–1344. 2002. View Article : Google Scholar : PubMed/NCBI
57	Hu Q, Lu YY, Noh H, Hong S, Dong Z, Ding HF, Su SB and Huang S: Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression. Oncogene. 32:3933–3943. 2013. View Article : Google Scholar
58	Wang SJ, Tu HP, Ko AM, Chiang SL, Chiou SJ, Lee SS, Tsai YS, Lee CP and Ko YC: Lymphocyte α-kinase is a gout-susceptible gene involved in monosodium urate monohydrate-induced inflammatory responses. J Mol Med (Berl). 89:1241–1251. 2011. View Article : Google Scholar